Company Filing History:
Years Active: 2015-2018
Title: Innovations by Isabelle Chacornac: Pioneering Vaccine Storage and Formulation Methods
Introduction
Isabelle Chacornac, an accomplished inventor based in Tupin et Semons, France, has made significant contributions to the field of vaccine development. With a total of three patents to her name, she specializes in methods that enhance the stability and efficacy of vaccine formulations, particularly those containing aluminum adjuvants.
Latest Patents
Chacornac's latest innovations include:
1. **Method of storing a vaccine containing an aluminum adjuvant** - This patent describes a novel technique for loading and storing vaccine compositions containing antigens adsorbed on aluminum adjuvants. The method involves sealing the composition in a container with a surface that is coated with a fluoropolymer, such as Teflon™, to ensure optimal stability of the adsorbed antigen during storage. The invention also features potential applications for vaccines such as the hepatitis B vaccine.
2. **Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminum oxyhydroxide** - This patent outlines a method for creating a vaccine that includes aluminum oxyhydroxide and a combination of the hepatitis B surface antigen and type b antigen. The uniqueness of this formulation lies in the way the hepatitis B surface antigen is adsorbed onto the aluminum compound, while the Hib antigen remains nonadsorbed, helping to improve the overall vaccine effectiveness.
Career Highlights
Throughout her career, Isabelle Chacornac has worked with prominent companies in the pharmaceutical sector, including Sanofi Pasteur Inc. and Sanofi Pasteur S.A. Her expertise in vaccine technology has made her a key asset in the development of new and improved vaccine formulations.
Collaborations
Chacornac has collaborated with several esteemed colleagues, including Sandrine Lentsch Graf and Nabila Ikhelef-Gribi. Their teamwork has contributed to her successful patent applications and advancements in vaccine technology, emphasizing the importance of collaboration in scientific innovation.
Conclusion
Isabelle Chacornac's patents reflect her commitment to improving vaccine development processes and enhancing public health. Her pioneering work in the field continues to inspire fellow inventors and researchers, propelling the industry towards more effective and stable vaccine solutions.